Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew UI elements include a glossary display option and updated footer/version labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed on the page. This is a minor metadata update and does not change the study information.SummaryDifference0.1%

- Check50 days agoChange DetectedFooter revision updated to Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.SummaryDifference0.1%

- Check71 days agoChange DetectedMinor revision update from v3.3.1 to v3.3.2; no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not be about the study, and the revision tag updated to v3.3.1.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page no longer displays the temporary notice about government funding lapses and NIH Clinical Center operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.